Burton DR - Search Results

1

Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers.

Hessell AJ, Rakasz EG, Poignard P, Hangartner L, Landucci G, Forthal DN, Koff WC, Watkins DI, Burton DR. Hessell AJ, et al. Among authors: burton dr. PLoS Pathog. 2009 May;5(5):e1000433. doi: 10.1371/journal.ppat.1000433. Epub 2009 May 15. PLoS Pathog. 2009. PMID: 19436712 Free PMC article.

2

Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site.

Parren PW, Ditzel HJ, Gulizia RJ, Binley JM, Barbas CF 3rd, Burton DR, Mosier DE. Parren PW, et al. Among authors: burton dr. AIDS. 1995 Jun;9(6):F1-6. doi: 10.1097/00002030-199506000-00001. AIDS. 1995. PMID: 7662189

3

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody.

Burton DR, Pyati J, Koduri R, Sharp SJ, Thornton GB, Parren PW, Sawyer LS, Hendry RM, Dunlop N, Nara PL, et al. Burton DR, et al. Science. 1994 Nov 11;266(5187):1024-7. doi: 10.1126/science.7973652. Science. 1994. PMID: 7973652

4

In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelope.

Parren PW, Fisicaro P, Labrijn AF, Binley JM, Yang WP, Ditzel HJ, Barbas CF 3rd, Burton DR. Parren PW, et al. Among authors: burton dr. J Virol. 1996 Dec;70(12):9046-50. doi: 10.1128/JVI.70.12.9046-9050.1996. J Virol. 1996. PMID: 8971041 Free PMC article.

5

Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design.

Parren PW, Gauduin MC, Koup RA, Poignard P, Fisicaro P, Burton DR, Sattentau QJ. Parren PW, et al. Among authors: burton dr. Immunol Lett. 1997 Jun 1;57(1-3):105-12. doi: 10.1016/s0165-2478(97)00043-6. Immunol Lett. 1997. PMID: 9232434 Corrected and republished. Review.

6

Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design".

Parren PW, Gauduin MC, Koup RA, Poignard P, Sattentau QJ, Fisicaro P, Burton DR. Parren PW, et al. Among authors: burton dr. Immunol Lett. 1997 Jul;58(2):125-32. doi: 10.1016/s0165-2478(97)00109-0. Immunol Lett. 1997. PMID: 9271324 Review.

7

A vaccine for HIV type 1: the antibody perspective.

Burton DR. Burton DR. Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10018-23. doi: 10.1073/pnas.94.19.10018. Proc Natl Acad Sci U S A. 1997. PMID: 9294155 Free PMC article. Review.

8

The antibody response in HIV-1 infection.

Burton DR, Montefiori DC. Burton DR, et al. AIDS. 1997;11 Suppl A:S87-98. AIDS. 1997. PMID: 9451972 Review. No abstract available.

9

Antibody neutralization-resistant primary isolates of human immunodeficiency virus type 1.

Parren PW, Wang M, Trkola A, Binley JM, Purtscher M, Katinger H, Moore JP, Burton DR. Parren PW, et al. Among authors: burton dr. J Virol. 1998 Dec;72(12):10270-4. doi: 10.1128/JVI.72.12.10270-10274.1998. J Virol. 1998. PMID: 9811774 Free PMC article.

10

Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines.

Sakurai H, Williamson RA, Crowe JE, Beeler JA, Poignard P, Bastidas RB, Chanock RM, Burton DR. Sakurai H, et al. Among authors: burton dr. J Virol. 1999 Apr;73(4):2956-62. doi: 10.1128/JVI.73.4.2956-2962.1999. J Virol. 1999. PMID: 10074145 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

660 results

Search Page